Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.50
Bid: 8.40
Ask: 8.60
Change: 0.10 (1.19%)
Spread: 0.20 (2.381%)
Open: 8.40
High: 8.50
Low: 8.25
Prev. Close: 8.40
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Seed Investment in Bond Pets LLC

5 Sep 2019 07:00

RNS Number : 2626L
Agronomics Limited
05 September 2019
 

5 September 2019

 

Agronomics Limited 

("Agronomics" or the "Company")

 

Seed Investment in Bond Pets LLC

 

The Board of AIM-quoted Agronomics, trading under the symbol ANIC, is pleased to announce that the Company has today subscribed for US $150,000 of convertible promissory notes (the "Subscription") in Bond Pets LLC's ("Bond"). The Subscription, funded from existing cash resources, is in line with the Company's investing strategy by participating in clean meat opportunities globally and, under the terms of the Subscription, will give the Company an approximate 3% to 4% equity interest in the Company, dependent on the valuation of Bond upon conversion.

 

Bond was co-founded by Rich Kelleman, CEO and Pernilla Audibert, CTO in 2018. Bond is a leader in the animal-free pet food sector and is, as far as the Company is aware, currently the only operation in the world producing chicken protein using fermentation techniques for incorporation into pet food products. Bond anticipates the launch of its first protein-rich dog treats in the US in Q1 2020 under the Bond Pet Foods brand.

 

Bond is an early stage, pre-revenue company with a cash burn rate of US $8,500 per month and net assets of approximately US$ 113,700 as at 31st July 2019.

 

Zion Research expect the US pet food market to reach US $30.01 billion in sales in 2022, with dog food accounting for approximately 70% of the market. Chicken is a popular flavour globally, found predominantly in both dog and cat food. The investment supports concerns of animal welfare within the pet food industry and the wider growing concerns of meat consumption in relation to climate change.

 

Richard Reed, Chairman of Agronomics, commented: -

 

"Bond Pet Foods represents an opportunity to expand our mission and remove animals from the pet food supply chain reduce the strain on the scarce resources of land, water and energy. With a simpler regulatory path for pet food, Bond has the opportunity to generate revenues"

 

Rich Kelleman, founder and CEO of Bond, added: -

 

"We're thrilled with Agronomics' commitment to our venture and are excited to have them on our team. Together we will deliver high quality protein and nutrition to dogs and cats - some of the world's biggest consumers of meat products - and help mitigate many of the negative impacts inherent with meat production."

 

Terms of the Convertible Promissory Note

 

Total Raise: US$ 1 million, inclusive of US$ 175,000 of already-issued notes

Pre-money valuation: US$ 3.6 million

Lead Investor: Hexagon Special Opportunities SPC

Liquidation preference: 1x

Mandatory conversion: Next qualifying financing shall convert to shares of capital stock at the conversion price of 80% of the prior preferred stock or after 24 months (the maturity date)

Pre-emption rights: Yes - the right to purchase the portion of equity securities offered by the Company equal to the number of shares of Company securities held. Oversubscription right with respect to shares.

5% option pool allocated prior to the Conversion of the Notes

 

About Bond Pets

 

Bond Pets LLC is a Boulder, Colorado-based pet food company that's reinventing pet nutrition, making dog and cat foods sourced from real meat protein, without the animal. Using some of the same processes that are employed in craft brewing, Bond grows high-quality animal proteins through fermentation, harvests them to better meet the nutrition requirements of companion animals, and uses the ingredients as the foundation of its complete recipes.

 

About Agronomics Limited

 

Agronomics Limited is an investment company focused on opportunities within the nascent industry of modern foods, which are environmentally friendly alternatives to the traditional production of meat and plant-based sources of nutrition. It established an investment policy in April 2019, with a board of directors including Richard Reed, Jim Mellon, David Giampaolo, Denham Eke and Anderson Whamond. The Agronomics team are highly experienced entrepreneurs, investors and advisors with a track record of success.

Agronomics believes that the recent developments within cellular agriculture and alternative protein space will provide valuable contributions to meet the demands of increased global population growth and meat consumption in the future. The company sees cellular agriculture and aquaculture (also called cell-based or "clean meat") as a viable solution to relieve the pressure on arable farming and land usage.

For further information, please contact:

Agronomics Limited

Beaumont Cornish Limited

Optiva Securities Limited

Peterhouse Capital Limited

Britton Financial PR

The Company

Nomad

Joint Broker

Joint Broker

Investor Relations

Denham Eke

+44 (0) 1624 639396

Roland Cornish/James Biddle

+44 (0) 207 628 3396

Jeremy King

+44 (0) 203 137 1904

Lucy Williams

+44 (0) 207 469 0936

 

Tim Blackstone

+44 (0)7957 140416

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLIMFTMBBMBLL
Date   Source Headline
29th Oct 20197:00 amRNSInvestment in Shiok Meats Pte. Ltd.
22nd Oct 20192:00 pmRNSCompany Newsletter
17th Oct 20197:00 amRNSInvestment in VitroLabs Inc
15th Oct 20197:00 amRNSInvestment in Rebellyous Foods
8th Oct 20197:00 amRNSNet Asset Value(s)
23rd Sep 20191:00 pmRNSAIM Rule 17 Notification
12th Sep 20197:00 amRNSInvestee Company Update
9th Sep 201911:55 amRNSHolding(s) in Company
5th Sep 20197:00 amRNSSeed Investment in Bond Pets LLC
29th Aug 20197:00 amRNSAgronomics Participates in BlueNalu Fund Raise
28th Aug 20199:42 amRNSNew website launched
27th Aug 20191:21 pmRNSInvestee company Update: Blue Nalu, Inc
12th Aug 201912:51 pmRNSHolding(s) in Company
5th Aug 20197:00 amRNSHolding(s) in Company
31st Jul 20197:00 amRNSNet Asset Value(s)
29th Jul 20197:00 amRNSInvestment in Simply Foods, Inc. (New Age Meats)
5th Jul 20194:40 pmRNSSecond Price Monitoring Extn
5th Jul 20194:35 pmRNSPrice Monitoring Extension
3rd Jul 201912:58 pmRNSResult of Meeting
17th Jun 20192:05 pmRNSSecond Price Monitoring Extn
17th Jun 20192:00 pmRNSPrice Monitoring Extension
17th Jun 201911:00 amRNSPrice Monitoring Extension
13th Jun 20197:00 amRNSEquity Fundraise Closes at £4.5 million
10th Jun 20197:00 amRNSProposed Equity Fundraise
31st May 20199:30 amRNSBoard Appointments
16th Apr 20191:01 pmRNSResult of Meeting
10th Apr 20197:00 amRNSNet Asset Value
29th Mar 20197:00 amRNSCircular and Notice of General Meeting
29th Mar 20197:00 amRNSHalf-year Report
7th Feb 20197:00 amRNSNet Asset Value(s)
28th Dec 20182:20 pmRNSFinal Results
24th Oct 20187:00 amRNSNet Asset Value(s)
16th Aug 20187:00 amRNSInvestment in Blue Nalu, Inc.
18th Jul 20187:00 amRNSNet Asset Value(s)
28th Jun 20187:00 amRNSInvestee Company Update: Summit Therapeutics plc
23rd Apr 20187:00 amRNSNet Asset Value(s)
27th Mar 20189:30 amRNSHalf-year Report
9th Feb 201812:31 pmRNSResult of AGM
8th Feb 20187:00 amRNSChange of Adviser
22nd Jan 20187:00 amRNSNet Asset Value(s)
28th Dec 20174:49 pmRNSFinal Results
19th Oct 20177:00 amRNSNet Asset Value(s)
20th Jul 201711:00 amRNSNAV & Investment in AgeX Therapeutics Inc.
25th Apr 20177:00 amRNSRedemption of Interest in Magna Biopharma Fund
12th Apr 20177:00 amRNSNet Asset Value(s)
29th Mar 20177:00 amRNSHalf-year Report
10th Feb 20175:29 pmRNSResult of AGM
12th Jan 20177:00 amRNSNet Asset Value(s)
23rd Dec 201612:00 pmRNSFinal Results and Notice of AGM
22nd Dec 20162:41 pmRNSLoan to the Diabetic Boot Company Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.